Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.730
+0.010 (0.37%)
At close: Nov 3, 2025, 4:00 PM EST
2.710
-0.020 (-0.73%)
After-hours: Nov 3, 2025, 4:00 PM EST
Alaunos Therapeutics Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Alaunos Therapeutics in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Alaunos Therapeutics.
Recommendation Trends
| Rating | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 16, 2023 |
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $225 | Hold → Strong Buy | Upgrades | $225 | +8,141.76% | May 15, 2023 |
| Wells Fargo | Wells Fargo | Buy Initiates $450 | Buy | Initiates | $450 | +16,383.52% | Mar 27, 2023 |
| Wells Fargo | Wells Fargo | Buy Initiates $450 | Buy | Initiates | $450 | +16,383.52% | Oct 4, 2022 |
Financial Forecast
Revenue This Year
568.06M
from 10.00K
Increased by 5,680,500.00%
Revenue Next Year
n/a
from 568.06M
EPS This Year
0.88
from -2.92
EPS Next Year
-0.14
from 0.88
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 584.8M | n/a |
| Avg | 568.1M | n/a |
| Low | 545.8M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 5,847,600.0% | - |
| Avg | 5,680,500.0% | - |
| Low | 5,457,800.0% | - |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.90 | -0.15 |
| Avg | 0.88 | -0.14 |
| Low | 0.84 | -0.14 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.